IN2013MU03847A - - Google Patents
Info
- Publication number
- IN2013MU03847A IN2013MU03847A IN3847MU2013A IN2013MU03847A IN 2013MU03847 A IN2013MU03847 A IN 2013MU03847A IN 3847MU2013 A IN3847MU2013 A IN 3847MU2013A IN 2013MU03847 A IN2013MU03847 A IN 2013MU03847A
- Authority
- IN
- India
- Prior art keywords
- composition
- relates
- linagliptin
- devoid
- amino acids
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
This present invention relates to pharmaceutical composition comprising fixed dose combination of linagliptin and metformin HCl wherein the composition is devoid of any basic amino acids. Further this invention also relates to process for the preparation of said composition & use of the said composition in treatment of certain diseases.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN3847MU2013 IN2013MU03847A (en) | 2013-12-09 | 2014-12-05 | |
PCT/IN2014/000751 WO2015107536A2 (en) | 2013-12-09 | 2014-12-05 | Fixed dose combination comprising linagliptin and metformin hci |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN3847MU2013 IN2013MU03847A (en) | 2013-12-09 | 2014-12-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2013MU03847A true IN2013MU03847A (en) | 2015-07-24 |
Family
ID=53543573
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN3847MU2013 IN2013MU03847A (en) | 2013-12-09 | 2014-12-05 |
Country Status (2)
Country | Link |
---|---|
IN (1) | IN2013MU03847A (en) |
WO (1) | WO2015107536A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TR201721505A2 (en) * | 2017-12-25 | 2019-07-22 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | The combination comprising linagliptin and metformin |
TR201721824A2 (en) * | 2017-12-26 | 2019-07-22 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | A MODIFIED EMISSION COMBINATION CONTAINING LINAGLIPTIN AND METFORMIN |
EP4373482A1 (en) | 2021-07-22 | 2024-05-29 | KRKA, D.D., Novo Mesto | Process for preparing a pharmaceutical composition comprising linagliptin and metformin hydrochloride |
CN116211819A (en) * | 2023-04-12 | 2023-06-06 | 华润双鹤药业股份有限公司 | Liagliptin metformin hydrochloride multi-layer tablet and preparation method thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UY33937A (en) * | 2011-03-07 | 2012-09-28 | Boehringer Ingelheim Int | PHARMACEUTICAL COMPOSITIONS CONTAINING DPP-4 AND / OR SGLT-2 AND METFORMIN INHIBITORS |
US9555001B2 (en) * | 2012-03-07 | 2017-01-31 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition and uses thereof |
-
2014
- 2014-12-05 IN IN3847MU2013 patent/IN2013MU03847A/en unknown
- 2014-12-05 WO PCT/IN2014/000751 patent/WO2015107536A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2015107536A2 (en) | 2015-07-23 |
WO2015107536A3 (en) | 2015-11-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12016501139A1 (en) | Bicyclic heterocycle compounds and their uses in therapy | |
PH12015500274B1 (en) | Alkylpyrimidine derivatives for the treatment of viral infections and further diseases | |
IN2014MN02069A (en) | ||
IN2014MN00948A (en) | ||
IN2014MN00986A (en) | ||
IN2014MN00987A (en) | ||
PH12014501984A1 (en) | Pharmaceutical compositions comprising metformin and a dpp-4 inhibitor or a sglt-2 inhibitor | |
IN2014MN02049A (en) | ||
PH12015500713A1 (en) | Acylaminopyrimidine derivatives for the treatment of viral infections and further diseases | |
IN2012MN02591A (en) | ||
MX347966B (en) | Quinazoline derivatives for the treatment of viral infections and further diseases. | |
MY182558A (en) | 1,2,4-triazine derivatives for the treatment of viral infections | |
IN2015DN01164A (en) | ||
MY181828A (en) | Bicyclically substituted uracils and the use therapy | |
IN2015DN01165A (en) | ||
PH12016502352A1 (en) | Pharmaceutical composition | |
TW201613578A (en) | Pharmaceutical combinations | |
IN2013MU03847A (en) | ||
PH12017501694A1 (en) | Compositions for the treatment of fibrosis and fibrosis-related diseases | |
PH12015501179A1 (en) | Fixed dose pharmaceutical composition comprising mometasone and azelastine | |
IN2014DN10683A (en) | ||
IN2013MU01223A (en) | ||
IN2013MU01222A (en) | ||
IN2013MU01225A (en) | ||
IN2013MU01224A (en) |